US2001014686A1PendingUtilityA1
Determining effects of external stimuli on the brain using pet
Priority: Sep 1, 1995Filed: Jan 17, 2001Published: Aug 16, 2001
Est. expirySep 1, 2015(expired)· nominal 20-yr term from priority
A61K 51/0491
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of evaluating the effects of administering an external stimuli or treatment such as a psychoactive compound, a drug, or an environmental influence like temperature, noise, vibration, light and similar sensory-perceived influences, on a subject's brain using imaging techniques with position emission tomography (PET). The method measures cerebral metabolism before and after administering the external stimuli or treatment, and employs a behavioral clamp to control behavioral influences on the subject's brain after administration of the external stimuli or treatment.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A method of evaluating the effects of administering an external stimuli to a subject on the subject's brain, comprising the steps of:
measuring cerebral metabolism of a subject's brain prior to any treatment with an external stimuli; administering the external stimuli to the subject; controlling behavioral influences on the subject's brain by subjecting the subject to a behavioral clamp; measuring cerebral metabolism of the subject's brain after administering the external stimuli and during the behavioral clamp; and determining any differences between cerebral metabolism prior to administering the external stimuli and cerebral metabolism after administering the external stimuli.
2 . The method of claim 1 wherein said external stimuli is a psychoactive compound.
3 . The method of claim 2 wherein the compound administered is a fragrance.
4 . The method of claim 2 wherein the compound administered is fluoxetine.
5 . The method of claim 2 wherein the compound administered is ethanol.
6 . The method of claim 2 wherein the compound administered is pimizide.
7 . The method of claim 2 wherein the compound administered is nimodopine.
8 . The method of claim 1 wherein the step of measuring cerebral metabolism prior to any treatment utilizes position emission tomography.
9 . The method of claim 1 wherein the step of measuring cerebral metabolism after administering the external stimuli utilizes position emission tomography.
10 . The method of claim 1 wherein said behavioral clamp comprises a visual monitoring task performed by the subject.
11 . The method of claim 1 further including the step of measuring a subject's mood both prior to and after administering the external stimuli.
12 . The method of claim 1 wherein the step of measuring a subject's mood comprises administering a standard psychological test thereto.
13 . The method of claim 12 wherein said standard psychological test is a profile of mood states.
14 . The method of claim 1 further including the step of comparing the cerebral metabolism after administering the external stimuli to a reference cerebral metabolism.
15 . The method of claim 1 wherein said external stimuli is a pharmaceutical drug.
16 . The method of claim 1 wherein said external stimuli is an environmental influence.
17 . The method of claim 16 wherein said environmental influence is selected from the group consisting of temperature, vibration, noise, and light.
18 . A method of evaluating the effects on a subject's brain of administering an external treatment to a subject comprising the following steps:
measuring cerebral metabolism of a subject's brain in the absence of any external treatment administration; administering an external treatment to the subject; controlling behavioral influences on the subject's brain by using a behavioral clamp, said behavioral clamp comprising a procedure that:
(a) maintains the subject in a standard and stable condition throughout a period of accumulation of cerebral metabolic information with and without said external treatment;
(b) is capable of being performed by the subject at comparable levels prior to as well as subsequent to administration of said external treatment;
(c) requires a non-stressful level of attention with no opportunity for the subject to develop a productive strategy;
(d) includes measurable variables capable of defining desired criteria; and
(e) minimizes subjective variables including extraneous ideation, motivation, and anxiety;
measuring cerebral metabolism to the subject's brain after administering the external treatment and during the behavioral clamp; and determining any differences between cerebral metabolism in the absence of administering the external treatment and cerebral metabolism after administering the external treatment.
19 . The method of claim 18 wherein said external treatment is selected from the group consisting of a psychoactive compound, a pharmaceutical drug and an environmental influence.Join the waitlist — get patent alerts
Track US2001014686A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.